Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. | Cancers (Basel) | 2022 | 35681798 | PubTator, text mining | PubMed |
| Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer's Disease. | Cells | 2022 | 35681440 | PubTator, text mining | PubMed |
| EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma. | Clin Cancer Res | 2022 | 35653119 | PubTator, text mining | PubMed |
| Epigenomic analysis reveals prevalent contribution of transposable elements to cis-regulatory elements, tissue-specific expression, and alternative promoters in zebrafish. | Genome Res | 2022 | 35649578 | PubTator, text mining | PubMed |
| Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning. | Elife | 2022 | 35639599 | PubTator, text mining | PubMed |
| Recent Advances in Syndactyly: Basis, Current Status and Future Perspectives. | Genes (Basel) | 2022 | 35627156 | PubTator, text mining | PubMed |
| Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer. | Biomedicines | 2022 | 35625783 | PubTator, text mining | PubMed |
| Elucidating the importance and regulation of key enhancers for human MEIS1 expression. | Leukemia | 2022 | 35624144 | PubTator, text mining | PubMed |
| ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly. | ERJ Open Res | 2022 | 35615418 | PubTator, text mining | PubMed |
| Tensile-Strained Palladium Nanosheets for Synthetic Catalytic Therapy and Phototherapy. | Adv Mater | 2022 | 35610760 | PubTator, text mining | PubMed |
| Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma. | Front Genet | 2022 | 35591854 | PubTator, text mining | PubMed |
| The role of biomarkers in personalized immunotherapy. | Biomark Res | 2022 | 35585623 | PubTator, text mining | PubMed |
| Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA. | Int J Mol Sci | 2022 | 35563278 | PubTator, text mining | PubMed |
| Integrated computational analysis reveals HOX genes cluster as oncogenic drivers in head and neck squamous cell carcinoma. | Sci Rep | 2022 | 35562533 | PubTator, text mining | PubMed |
| Genetic determinants of syndactyly: perspectives on pathogenesis and diagnosis. | Orphanet J Rare Dis | 2022 | 35549993 | PubTator, text mining | PubMed |
| Benign and malignant diagnosis of spinal tumors based on deep learning and weighted fusion framework on MRI. | Insights Imaging | 2022 | 35536493 | PubTator, text mining | PubMed |
| Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer. | Front Oncol | 2022 | 35530332 | PubTator, text mining | PubMed |
| Identification of novel key regulatory lncRNAs in gastric adenocarcinoma. | BMC Genomics | 2022 | 35525925 | PubTator, text mining | PubMed |
| Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued. | Infect Drug Resist | 2022 | 35517900 | PubTator, text mining | PubMed |
| Plasmonic nanosensors for point-of-care biomarker detection. | Mater Today Bio | 2022 | 35514435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=24